Cargando…

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD

BACKGROUND: Chronic posttraumatic stress disorder (PTSD) is a disabling condition that generates considerable morbidity, mortality, and both medical and indirect social costs. Treatment options are limited. A novel therapy using 3,4-methylenedioxymethamphetamine (MDMA) has shown efficacy in six phas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marseille, Elliot, Kahn, James G., Yazar-Klosinski, Berra, Doblin, Rick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556534/ https://www.ncbi.nlm.nih.gov/pubmed/33052965 http://dx.doi.org/10.1371/journal.pone.0239997

Ejemplares similares

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
por: Feduccia, Allison A., et al.
Publicado: (2019)

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
por: Wagner, Mark T, et al.
Publicado: (2017)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
por: Mithoefer, Michael C., et al.
Publicado: (2019)

MDMA-assisted psychotherapy for the treatment of PTSD
por: Reiff, Collin M., et al.
Publicado: (2020)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
por: Ponte, Linnae, et al.
Publicado: (2021)

The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study
por: Avanceña, Anton L. V., et al.
Publicado: (2022)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
por: Wolfson, Philip E., et al.
Publicado: (2020)

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Gorman, Ingmar, et al.
Publicado: (2020)

Psychotherapy-supported MDMA treatment for PTSD
por: Krystal, John H., et al.
Publicado: (2021)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
por: Morgan, Louise
Publicado: (2020)

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
por: Mitchell, Jennifer M., et al.
Publicado: (2023)

A comparison of mdma-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
por: Illingworth, B., et al.
Publicado: (2021)

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
por: Danforth, Alicia L., et al.
Publicado: (2018)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
por: Marseille, Elliot, et al.
Publicado: (2022)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
por: Christie, Devon, et al.
Publicado: (2022)

Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD
por: Lewis, Candace R., et al.
Publicado: (2023)

Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
por: Marseille, Elliot, et al.
Publicado: (2022)

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
por: Ot’alora G, Marcela, et al.
Publicado: (2018)

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
por: Stauffer, Christopher S., et al.
Publicado: (2022)

Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA
por: Nair, Jay B., et al.
Publicado: (2021)

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial
por: Monson, Candice M., et al.
Publicado: (2020)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
por: Mitchell, Jennifer M., et al.
Publicado: (2021)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
por: Mithoefer, Michael C, et al.
Publicado: (2013)

Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD
por: Van Der Kolk, B.
Publicado: (2021)

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
por: Godes, Macha, et al.
Publicado: (2023)

MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
por: Riaz, Kainat, et al.
Publicado: (2023)

Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
por: Cohen, Isaac Victor, et al.
Publicado: (2021)

Premise, promise and challenges of MDMA assisted therapy for PTSD
por: Madero, Santiago, et al.
Publicado: (2023)

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
por: Feduccia, Allison A., et al.
Publicado: (2020)

The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
por: Bonn-Miller, Marcel O., et al.
Publicado: (2021)

Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
por: Mithoefer, Michael C, et al.
Publicado: (2011)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

Correction to: Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
por: Jardim, Alvaro V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_idm9uscdkpho075lp29dkhvfer